Drugs ultrasonic delivery

One of the main problems opposing introduction of the new drugs into clinical practice lies in complexity of the drug delivery to the target cells. The role of ultrasound is rapidly growing in delivery of the therapeutic agents, including genetic material, proteins and chemotherapeutic agents. Since the ultrasound exposure is a widely available and relatively inexpensive method, such drug delivery could be considered a promising approach to the treatment of certain diseases. The paper analyzes methods of the ultrasound delivery of various drugs and principles underlying them, compiles their classification by the molecule type and considers certain organs and tissues from the point of view of their possibilities and prospects for introducing the ultrasound impregnation.

References

[1] Tzu-Yin W., Wilson K.E., Machtaler S., Willmann J.K. Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications. Curr. Pharm. Biotechnol., 2013, vol. 14, pp. 743–752. https://doi.org/10.2174/1389201014666131226114611

[2] Izadifar Z., Babyn P., Chapman D. Mechanical and biological effects of ultrasound: A review of present knowledge. Ultrasound in medicine & biology, 2017, vol. 43, no. 6, pp. 1085–1104. https://doi.org/10.1016/j.ultrasmedbio.2017.01.023

[3] Deng C.X., Sieling F., Pan H., Cui J. Ultrasound-induced cell membrane porosity. Ultrasound Med Biol, 2004, vol. 30, pp. 519–526. https://doi.org/10.1016/j.ultrasmedbio.2004.01.005

[4] Mitragotri S., Kost J. Low-frequency sonophoresis: a review. Advanced drug delivery reviews, 2004, vol. 56, no. 5, pp. 589–601. https://doi.org/10.1016/j.addr.2003.10.024

[5] Yamashita N. et al. Scanning electron microscopic evaluation of the skin surface after ultrasound exposure. The Anatomical Record: An Official Publication of the American Association of Anatomists, 1997, vol. 247, no. 4, pp. 455–461. https://doi.org/10.1002/(SICI)1097-0185(199704)247:4<455::AID-AR3>3.0.CO;2-Q

[6] Tezel A., Sens A., Mitragotri S. Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J. Pharm. Sci., 2002, vol. 91, pp. 444–453. https://doi.org/10.1002/jps.10024

[7] Mitragotri S. et al. A mechanistic study of ultrasonically enhanced transdermal drug delivery. Journal of pharmaceutical Sciences, 1995, vol. 84, no. 6, pp. 697–706. https://doi.org/10.1002/jps.2600840607

[8] Polat B.E., Blankschtein D., Langer R. Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs. Expert opinion on drug delivery, 2010, vol. 7, no. 12, pp. 1415–1432. https://doi.org/10.1517/17425247.2010.538679

[9] Yamaguchi K. et al. Ultrasound-mediated interferon ? gene transfection inhibits growth of malignant melanoma. Biochemical and biophysical research communications, 2011, vol. 411, no. 1, pp. 137–142. https://doi.org/10.1016/j.bbrc.2011.06.115

[10] Mitragotri S., Blankschtein D., Langer R. Ultrasound-mediated transdermal protein delivery. Science, 1995, vol. 269, no. 5225, pp. 850–853. https://doi.org/10.1126/science.7638603

[11] Gr?ll H., Langereis S. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. Journal of Controlled Release, 2012, vol. 161, no. 2, pp. 317–327. https://doi.org/10.1016/j.jconrel.2012.04.041

[12] Minchinton A.I., Tannock I.F. Drug penetration in solid tumours. Nat Rev Cancer., 2006, vol. 6, pp. 583–592. https://doi.org/10.1038/nrc1893

[13] Awad N.S. et al. Ultrasound-responsive nanocarriers in cancer treatment: A review. ACS Pharmacology & Translational Science, 2021, vol. 4, no. 2, pp. 589–612. https://doi.org/10.1021/acsptsci.0c00212

[14] Kaplun A.P., Bezrukov D.A., Shvets V.I. Rational design of nano- and micro-size medicinal forms of biologically active substances. Appl. Biochem. Microbiol., 2011, vol. 47 (8), pp. 711–717. https://doi.org/10.1134/S0003683811080072

[15] Chamundeeswari M., Jeslin J., Verma M.L. Nanocarriers for drug delivery applications. Environmental Chemistry Letters, 2019, vol. 17, pp. 849–865. https://doi.org/10.1007/s10311-018-00841-1

[16] Peer D., Karp J.M., Hong Seungpyo et al. Nano-Enabled Medical Applications. Chapter. Nanocarriers as an emerging platform for cancer therapy. Singapore, Jenny Stanford Publishing, 2020, pp. 61–91.

[17] Soo Choi H., Liu W., Misra P. et al. Renal clearance of quantum dots. Nat Biotechnol., 2007, vol. 25 (10), pp. 1165–1170. https://doi.org/10.1038/nbt1340

[18] Moghimi S.M., Hedeman H., Muir I.S., Illum L., Davis S.S. An 29. investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Biochim Biophys Acta – Gen Subj., 1993, vol. 1157 (2), pp. 233–240.

[19] Mitragotri S., Anselmo A.C. BioTM Buzz: The Future is Bright. Bioeng Transl Med., 2020, vol. 5, iss. 3. https://doi.org/10.1002/btm2.10185

[20] Cavadas M., Gonz?lez-Fern?ndez ?., Franco R. Pathogen-mimetic stealth nanocarriers for drug delivery: a future 32. possibility. Nanomedicine Nanotechnology, Biol Med., 2011, vol. 7 (6), pp. 730–743. https://doi.org/10.1016/j.nano.2011.04.006

[21] Hossen S. et al. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. Journal of advanced research, 2019, vol. 15, pp. 1–18. https://doi.org/10.1016/j.jare.2018.06.005

[22] Chen H., Hwang J.H. Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors. Journal of therapeutic ultrasound, 2013, vol. 1, no. 1, pp. 1–8.

[23] Pitt W.G., Husseini G.A., Staples B.J. Ultrasonic drug delivery – a general review. Expert opinion on drug delivery, 2004, vol. 1, no. 1, pp. 37–56. https://doi.org/10.1517/17425247.1.1.37

[24] Hernot S., Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv. Drug. Del. Rev., 2008, vol. 60, pp. 1153–1166. https://doi.org/10.1016/j.addr.2008.03.005

[25] Wischhusen J., Padilla F. Ultrasound-targeted microbubble destruction (UTMD) for localized drug delivery into tumor tissue. IRBM, 2019, vol. 40, no. 1, pp. 10–15. https://doi.org/10.1016/j.irbm.2018.11.005

[26] Lammertink B.H.A., Bos C., Deckers R., Storm G., Moonen C.T.W., Escoffre J.-M. Sonochemotherapy from bench to bedside. Front Pharmacol, 2015, vol. 6. https://doi.org/10.3389/fphar.2015.00138

[27] Yan F., Li L., Deng Z., Jin Q., Chen J., Yang W. et al. Paclitaxel-liposome – microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. J. Control Release, 2013, vol. 28, no. 166 (3), pp. 246–255. https://doi.org/10.1016/j.jconrel.2012.12.025

[28] Amabile P.G. et al. High-efficiency endovascular gene delivery via therapeutic ultrasound. Journal of the American College of Cardiology, 2001, vol. 37, no. 7, pp. 1975–1980. https://doi.org/10.1016/s0735-1097(01)01253-0

[29] Schneider M.D., French B.A. The advent of adenovirus. Gene therapy for cardiovascular disease. Circulation, 1993, vol. 88, no. 4, pp. 1937–1942. https://doi.org/10.1161/01.cir.88.4.1937

[30] Newman K.D. et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. The Journal of clinical investigation, 1995, vol. 96, no. 6, pp. 2955–2965. https://doi.org/10.1172/JCI118367

[31] Scott R.C. et al. Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue. Expert opinion on drug delivery, 2008, vol. 5, no. 4, pp. 459–470. https://doi.org/10.1517/17425247.5.4.459

[32] Shohet R.V. et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation, 2000, vol. 101, no. 22, pp. 2554–2556. https://doi.org/10.1161/01.cir.101.22.2554

[33] Heath C.H., Sorace A., Knowles J., Rosenthal E., Hoyt K. Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in vitro and in vivo. Otolaryngol. Head Neck Surg., 2012, vol. 146, pp. 938–945. https://doi.org/10.1177/0194599812436648

[34] Escoffre J.M., Piron J., Novell A., Bouakaz A. Doxorubicin delivery into tumor cells with ultrasound and microbubbles. Mol. Pharm., 2011, vol. 8, pp. 799–806. https://doi.org/10.1021/mp100397p

[35] Ren S.T., Liao Y.R., Kang X.N., Li Y.P., Zhang H., Ai H. et al. The antitumor effect of a new docetaxel-loaded microbubble combined with low frequency ultrasound in vitro: preparation and parameter analysis. Pharm. Res., 2013, vol. 30, pp. 1574–1585. https://doi.org/10.1007/s11095-013-0996-5

[36] Iwanaga K., Tominaga K., Yamamoto K., Habu M., Maeda H., Akifusa S., et al. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther., 2007, vol. 14, pp. 354–363. https://doi.org/10.1038/sj.cgt.7701026

[37] Huber P.E. et al. Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery. Gene Therapy, 2003, vol. 10, no. 18, pp. 1600–1607. https://doi.org/10.1038/sj.gt.3302045

[38] Tachibana K., Tachibana S. Transdermal delivery of insulin by ultrasonic vibration. Journal of pharmacy and pharmacology, 1991, vol. 43, no. 4, pp. 270–271. https://doi.org/10.1111/j.2042-7158.1991.tb06681.x